# Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.

> **NCT06646328** · PHASE4 · TERMINATED · sponsor: **Fernando Sanchez** · enrollment: 20 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **PROCEDURE:** Central venous access
- **DEVICE:** Pump-assisted circuit
- **DRUG:** Heparin sodium
- **OTHER:** Regional citrate anticoagulation
- **PROCEDURE:** Blood and ultrafiltrate samples

## Key facts

- **NCT ID:** NCT06646328
- **Lead sponsor:** Fernando Sanchez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-09
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Enrollment slower than anticipated and interrupted by COVID-19 pandemic
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646328, "Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06646328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*